Autosomal dominant optic atrophy (ADOA) is a dominantly inherited optic neuropathy, affecting the specific loss of retinal ganglion cells (RGCs). The majority of affected cases of ADOA are associated with mutations in OPA1 gene. Our previous investigation identified the c.1198C > G (p.P400A) mutation in the OPA1 in a large Han Chinese family with ADOA. In this report, we performed a functional characterization using lymphoblostoid cell lines derived from affected members of this family and control subjects. Mutant cell lines exhibited the aberrant mitochondrial morphology. A ~24.6% decrease in the mitochondrial DNA (mtDNA) copy number was observed in mutant cell lines, as compared with controls. Western blotting analysis revealed the variable reductions (~45.7%) in four mtDNA-encoded polypeptides in mutant cell lines. The impaired mitochondrial translation caused defects in respiratory capacity. Furthermore, defects in mitochondrial ATP synthesis and mitochondrial membrane potential (ΔΨm) were observed in mutant cell lines. These abnormalities resulted in the accumulation of oxidative damage and increasing of apoptosis in the mutant cell lines, as compared with controls. All those alterations may cause the primary degeneration of RGCs and subsequent visual loss. These data provided the direct evidence for c.1198C > G mutation leading to ADOA. Our findings may provide new insights into the understanding of pathophysiology of ADOA.
Autosomal dominant optic atrophy (ADOA, OMIM 165500) is the most common inherited optic neuropathies, affecting one individual per 12,000 to 35,0001, 2. This disorder is characterized by an insidious loss of visual acuity in early childhood with color vision deficits, central scotoma (blind spot) and temporal or diffuse pallor of the optic disc3. The typical features in this disorder involve the primary degeneration of RGCs, and accompanied by ascending optic atrophy3,4,5. The clear autosomal dominant pattern of inheritance and congenital nature of ADOA can be distinguished it from Leber hereditary optic atrophy (LHON), which exhibited the maternal inheritance and late-onset of optic atrophy and was caused by mutations in mitochondrial DNA (mtDNA)5,6,7,8. Mutations among five genes OPA1, OPA3, OPA4, OPA5 and OPA8 have been identified to be associated with ADOA9,10,11,12,13. Of these, the OPA1 gene, encoding a mitochondrial dynamin-like GTPase protein, is the most prevalently causative gene for ADOA3, 9, 10, 14. About 350 variants of OPA1 gene, consisting of 30 exons, were identified from various ethnic origins (http://mitodyn.org/home.php)14. The majority of OPA1 mutations are located at the GTPase domain (Exons 8–15) and dynamin central regions (Exons 16–23)14. The primary defects of OPA1 were the altered mitochondrial fusion and morphology15,16,17. These mutations also affected the mitochondrial genome maintenance18, 19. As a result, mutations in OPA1 gene caused the deficient oxidative phosphorylation (OXPHOS) and sensitivity to apoptosis20,21,22,23,24.
Despite progress made in the identification of the genetic defects associated with ADOA in European and North American populations, less has been known about the pathogenesis of ADOA in the Asians, especially in the Chinese population. With aim to identify the molecular basis of ADOA in Chinese population, we recruited a large cohort of Chinese subjects with ADOA and LHON6,7,8. In our previous study, we reported a large four-generation Han Chinese family with ADOA25. Twelve of 44 family members were affected in this pedigree, and the ratio of affected male and female relatives was 1:1. The affected family members exhibited the early-onset and progressive visual impairment, ranging from mild to profound loss of visual acuity. The average age-at-onset was 14 years. The sequencing analysis of entire OPA1 gene identified a novel c.1198C > G (p.P400A) heterozygous mutation at the exon 12 in all affected members of this family. The p.P400A mutation located at a highly conserved residue of GTPase domain of this protein. To further investigate the pathogenic mechanism of the c.1198C > G (p.P400A) mutation, lymphoblastoid cell lines were generated from 3 affected members carrying the c.1198C > G mutation and 3 control subjects lacking any of OPA1 mutation. These cell lines were assessed for the effects of the OPA1 mutation on mitochondrial morphology, mtDNA copy number, oxygen consumption ratio (OCR), ATP production, mitochondrial membrane potential, generation of reactive oxygen species (ROS) and sensitivity to apoptosis.
The construction of lymphoblastoid cell lines
Immortalized lymphoblastoid cell lines used for biochemical assays were derived from three affected members carrying the c.1198C > G mutation and one vision normal member lacking the mutation of the family, and two genetically unrelated control individuals with the same mitochondrial background (Supplementary Figure 1a). The ages of four members (II-9, III-11, III-12 and IV-3) of this family were 47, 30, 27 and 6 years, respectively; while the ages of two Chinese control subjects (WZ11 and WZ12) were 42 and 8 years, respectively. The mtDNA haplogroups of these affected and control subjects belonged to Asian haplogroup M9. The Sanger sequence analysis confirmed the presence of the c.1198C > G heterozygous mutation in these cell lines derived from three relatives of this family but absence of the mutation in control subjects (Supplementary Figure 1b).
Alteration in mitochondrial morphology
To assess the effects of the OPA1 mutation on mitochondrial morphology, lymphoblastoid cell lines derived from one affected member (III-11) and one vision normal subject (III-12) were stained with mitochondrial-specific dye MitoTracker RedTM and with DNA specific dye DAPI and analyzed with a confocal microscope system. As shown in Fig. 1a, the mitochondria in OPA1 mutant cells (III-11) displayed a distinct punctate pattern, as compared with a balanced mitochondrial network in control cells (III-12). The mitochondria morphology from mutant and control lymphoblastoid cell lines was further examined by using transmission electron microscopy. As shown in Fig. 1b, the mutant cell lines showed the abnormal mitochondrial morphology including mitochondrial fragmentation, swollen and cristae structure, as compared with control cell lines. In particular, mutant cells exhibited a spotty distribution of mitochondria (5.9% with tubular and 94.1% with spotty) (spotty was defined as length of mitochondria < 0.60 μm, tubular as length > 0.60 μm), while the wild type cells displayed the tubular distribution of mitochondria (59.4% with tubular and 40.6% with spotty). In addition, the mitochondrial wide in the mutant cells were much larger than that of control cells (mutants 0.20–0.53 μm versus controls 0.13–0.33 μm). Furthermore, mitochondrial numbers in mutant cells ranged from 43.5% to 68.5%, with an average of 57%, related to average values of control cells. These results indicated that the c.1198C > G mutation resulted in the abnormality of mitochondrial morphology.
Decrease in mtDNA copy number
It was anticipated that the alteration in maintenance of mitochondrial genome caused by mutation in OPA 1 affected the copy number of mtDNA18. Here, we examined the mtDNA copy number by quantitative PCR using total genomic DNA as template. For this purpose, we made standard curve of three pairs of primers (MT-D-loop, MT-ND1 and β-actin), as shown in the Supplemental Figure 2. In particular, mtDNA contents were measured using fragments spanning the MT-D-loop region and MT-ND1 as mtDNA targets and nuclear coding β-actin as the normalization. As shown in Fig. 2, the contents of mtDNA copies in mutant cell lines, using fragments spanning the D-loop region, ranged from 70.6% to 80.7%, with an average of 75.4% (P = 0.0056) and using fragments spanning MT-ND1 gene, from 79.1% to 83.5%, with an average of 81.5% (P = 0.0103), respectively, related to average values of control cell lines.
Reduction in the level of mitochondrial proteins
To investigate whether the impairment of mitochondrial translation occurred in mutant cell lines, a Western blot analysis was carried out to examine the levels of four mtDNA-encoded respiratory complex subunits in mutant and control cell lines with a nuclear encoding mitochondrial protein VDAC as a loading control. As shown in Fig. 3a, the levels of p.MT-ND5 subunits 5 of NADH dehydrogenase; p.MT-Cytb, apocytochrome b; p.MT-CO2, subunits 2 of cytochrome c oxidase and p.MT-ATP6, subunit 6 of the H + -ATPase were decreased in three mutant cell lines, as compared with those of three control cell lines. As shown in Fig. 3b, the overall levels of four mitochondrial translation products in the mutant cell lines was decreased from 35.2% to 60.4%, with an average of 45.7% (P = 0.0002) of the man value measured in three control cell lines. Notably, the average levels of p.MT-ND5, p.MT-Cytb, p.MT-CO2 and p.MT-ATP6 in the mutant cell lines were 48.4%, 38.7%, 60.4% and 35.2% of the average values relative to the mean value measured in the control cell lines, respectively (Fig. 3c).
To evaluate if the c.1198C > G heterozygous mutation alters cellular bioenergetics, we measured the OCR of three mutant and three control cell lines using a Seahorse Bioscience XF-96 Extracellular Flux Analyzer. As shown in Fig. 4, the average basal OCR in three mutant cell lines was 53.9% (P = 0.0039) relative to the mean value measured in three control cell lines. To investigate which of the enzyme complexes of the respiratory chain was affected in the mutants, OCR were measured after the sequential addition of oligomycin (inhibit the ATP synthase), FCCP (to uncouple the mitochondrial inner membrane and allow for maximum electron flux through the electron transport chain), rotenone (to inhibit complex I) and antimycin A (to inhibit complex III)26,27,28. The difference between the basal OCR and the drug-insensitive OCR yields the amount of ATP-linked OCR, proton leak OCR, maximal OCR, reserve capacity and non-mitochondrial OCR. As shown in Fig. 4, the ATP-linked OCR, proton leak OCR, maximal OCR, reserve capacity and non-mitochondrial OCR in mutant cell lines were ~49.0%, 1.5%, 49.0%, 51.0% and 49.1%, relative to the mean value measured in the three control cell lines (P = 0.0114, 0.9606, 0.0036, 0.0219 and 0.1465), respectively.
Impaired mitochondrial ATP synthesis
The capacity of oxidative phosphorylation in mutant and control cells was examined by measuring the levels of cellular ATP using a luciferin/luciferase assay. Populations of cells were incubated in the media in the presence of glucose, glucose with oligomycin, and 2-deoxy-D-glucose (2-DG) with pyruvate27,28,29. The levels of ATP production in mutant cell lines in the presence of glucose (total cellular levels of ATP) or 2-DG with pyruvate to inhibit the glycolysis (oxidative phosphorylation) were comparable with those measured in the control cell lines. By contrast, total cellular levels of ATP have no difference between mutant and control cell lines (Fig. 5a), while the levels of ATP production from oxidative phosphorylation in the mutant cell lines, ranged from 52.1% to 76.8%, with an average of 66.8% relative to the mean value measured in three control cell lines (P = 0.0271) (Fig. 5b).
Decrease in mitochondrial membrane potential
The mitochondrial membrane potential (ΔΨm) alterations were measured using a fluorescence probe JC-10 assay system. The ratio of fluorescence intensities Ex/Em = 490/590 and 490/525 nm (FL590/FL525) were recorded to delineate the ΔΨm level of each sample. The relative ratios of FL590/FL525 geometric mean between mutant and control cell lines were calculated to represent the level of ΔΨm. As shown in Fig. 6, levels of the ΔΨm in the mutant cell lines carrying c.1198C > G mutation were decreased, ranging from 72.2% to 79.9%, with an average 76.5% (P = 0.0156) of the mean value measured in three control cell lines. By contrast, the levels of ΔΨm in mutant cell lines in the presence of FCCP were comparable with those measured in the control cell lines (P = 0.5986).
The increase of ROS production
The levels of the ROS generation in the vital cells derived from three affected relatives carrying the c.1198C > G mutation and three control individuals lacking this mutation were measured with flow cytometry under normal and H2O2 stimulation29, 30. Geometric mean intensity was recorded to measure the rate of ROS in each sample. The ratio of geometric mean intensity between unstimulated and stimulated cell lines with H2O2 was calculated to delineate the reaction upon increasing level of ROS under oxidative stress. As shown in Fig. 7a and c, the levels of ROS generation in the lymphoblastoid cell lines derived from three affected individuals carrying the c.1198C>G mutation were reduced, ranging from 114.1% to 127.1%, with an average of 121.4% (P = 0.0090) of the mean value measured in three control cell lines. Furthermore, the levels of mitochondrial ROS (mito-ROS) among lymphoblastoid cell lines were determined using a MitoSOX assay via flow cytometry31, 32. As show in Fig. 7b and d, the levels of mitochondrial ROS generation in the mutant cell lines ranged from 109.2% to 122.3%, with an average of 116.7%(P = 0.0142) of the man value measured in three control cell lines.
Defects in cell apoptosis
To evaluate if the c.1198C > G mutation affects the apoptotic process, we examined the apoptotic state of mutant and control lymphoblastoid cell lines by using immunocytostaining with the antibodies and analyzed with a confocal microscope system and Western blotting analysis. Figure 8a shows the immunofluorescence pattern of lymphoblastoid cell lines double labeled with rabbit monoclonal antibody specific for the Cytochrome C and mouse monoclonal antibody to TOM20, a nuclear encoding protein in the mitochondrial inner membrane. As shown in Fig. 8b and c, the levels of cytochrome c in the mutant cell lines increased 143.7%, as compared with the average values in control cell lines. To further analyze if the c.1198C > G mutation affects apoptosis, we measured the levels of apoptosis-related proteins: PARP, as well as caspases 3, 7 and 9 in mutant and control cell lines by Western blot analysis. As showed in Fig. 8d and e, the average levels of PARP protein, caspase 3, caspase 7 and caspase 9 in the mutant cell lines were 133.7%, 135.3%, 133.1% and 137.3% of the average values measured in the control cell lines, respectively (P = 0.0497, 0.0050, 0.0136 and 0.0489).
The OPA1 gene encoding a mitochondrial dynamin-like GTPase protein is the most important causative gene for ADOA. Indeed, OPA1 is a critical factor connecting the mitochondrial morphology and energetics. In this investigation, we characterized the novel c.1198C > G (p. P400A) mutation in OPA1 gene using lymphoblastoid cell lines generated from members of a large Chinese family with ADOA. The p. P400A mutation was located at a highly conserved residue of GTPase domain where the majority of pathogenic mutations in OPA1 gene cluster14. The G401 residue is one of the key residues in the G3 (DxxG) motif and may form a hydrogen bond with the γ-phosphate of GTP15. Furthermore, the p.P400A mutation may also cause misalignment of GTP in the GTP-binding pocket of the GTPase domain of OPA1, resulting in mitochondrial dysfunction25. It was anticipated that the p.P400A mutation caused the mitochondrial fragmentation, instability of mtDNA, and OXPHOS defect. The primary defects in the mutations of OPA1 gene appeared to alter the mitochondrial morphology and fusion16, 33,34,35,36. In the present study, mutant lymphoblastoid cell lines carrying the heterozygous c.1198C > G mutation revealed the altered mitochondrial dynamics and led to the fragmented network, compared with control cell lines. In particular, the mutant cells exhibited the perturbed mitochondrial morphology including mitochondrial fragmentation, swollen and cristae structure and spotted distribution of mitochondria, as in the case of cell lines carrying the other OPA1 mutations16, 36. In fact, the altered fusion activity and the increase in mitochondrial network fragmentation in mutant cells carrying the c.1198C > G mutation may be due to the dominant negative effect17.
The OPA1/MGM1 are required for the maintenance of mitochondrial genomes18. The mutations in OPA1 gene led to the depletion of mtDNA in cells and skeletal muscular tissues derived from ADOA subjects37, 38. In the present study, 24.6% decreases in mtDNA content observed in mutant cells were due to the unstable maintenance of mtDNA caused by the OPA1 mutation. The unstablity of mtDNA caused by the OPA1 mutation contributed to the deficient mitochondrial translation. In the present study, a markedly decreased level of mitochondrial proteins (an average decrease of ~45.7%) was observed in mutant cells, as compared to the average levels in control cells. The reduced level of variable mitochondrial proteins detected in lymphoblastoid cell lines using a Western blot analysis was comparable with the reduced rate of mitochondrial protein synthesis observed in cell lines carrying mtDNA mutations27, 31. The impairment of mitochondrial translation then resulted in the respiration defects. In particular, alteration in mitochondrial protein synthesis was apparently responsible for the significant reduced rates in the basal OCR, ATP-linked OCR, maximal OCR and reserve capacity OCR in the control and mutant cell lines. This correlation is clearly consistent with the importance that OPA1 mutation plays a critical role in producing their respiration defects, as in the cases of cells both carrying the homozygous YARS2 c.572G > T and LHON-associated m.11778G > A mutations28. The respiratory deficiency then affects the efficiency of mitochondrial ATP synthesis. Our study showed that these lymphoblastoid cell lines carrying the OPA1 mutation had 33.2% decrease in the mitochondrial ATP production. These results were consistent with other report, showing significant reductions in the ATP content in cell lines carrying the other OPA1 mutations18. Furthermore, our previous investigations revealed the marked decreases in mitochondrial ATP production in lymphoblastoid cell lines derived from Chinese pedigrees with LHON28, 29. Alternatively, the reduction in mitochondrial ATP production in mutant cells was likely a consequence of the decrease in the proton electrochemical potential gradient of mutant mitochondria39. As a result, RGC cells carrying the OPA1 mutation may be particularly sensitive to decreased ATP demand. Furthermore, the deficient activities of respiratory chain complexes often alter mitochondrial membrane potentials, which indicated the viability of cells40. In this investigation, 24% reduction in mitochondrial membrane potential in lymphoblastoid cell lines carrying the OPA1 mutation was observed, which was lower than those in cell lines carrying the m.12201T > C mutation in the tRNAHis gene 27. The defects in mitochondrial membrane potential may be due to strongly decreased efficiency of respiratory chain mediated proto extrusion for the matrix. The impairment of OXPHOS can lead to more electron leakage from electron transport chain, and in turn, elevate the production of ROS in mutant cells41. In the present study, the levels of ROS generation in the lymphoblastoid cell lines derived from three affected individuals carrying this mutation were 21.4% higher than control cell lines, and mitochondrial ROS generation increased 16.7% in the mutants, while 47% increase of ROS production in cells carrying both m.11778G > A and homozygous YARS2 c.572G > T mutations was the consequence of the altered activities of complexes I and IV28. The overproduction of ROS can establish a vicious cycle of oxidative stress in the mitochondria, thereby damaging mitochondrial and cellular proteins, lipids and nuclear acids42.
Apoptosis is the final common pathway leading to RGCs loss in ADOA and cell death is likely being complex, being triggered by a combination of several interacting factors. The two best-understood activation mechanisms are the intrinsic pathway (also called the mitochondrial pathway) and the extrinsic pathway43, 44. At a molecular level, apoptosis is regulated by two protein families: the Bcl-2 family which is responsible for the initiation phase, and the caspase family of proteases are that are involved in the execution phase of apoptosis45, 46. Mitochondrial cytochrome c plays an important role in the propagation of many pro-apoptotic signals through acting as a co-factor for a caspase-activating complex in the cytoplasm, called the apoptosome. As a result, release of cytochrome c from the mitochondrial intermembrane space (IMS) represents an important checkpoint in apoptosis42, 47. Downregulation of OPA1 leads to aberrant cristae remodeling and the release of cytochrome c which is normally sequestered within the tight cristae junctions23. In the present investigation, immunocytostaining on cytosolic and mitochondrial fractions showed that the levels of cytochrome c in mutant cell lines was higher than in control cell lines. Furthermore, Western blot analysis demonstrated that levels of the cytochrome c mutants exhibited markedly higher than those in control cell lines. In addition, the levels of apoptosis-related proteins: PARP, as well as caspases 3, 7 and 9 in the mutant cell lines were significantly higher those in control cell lines. These data demonstrated that c.1198G > C mutation in the OPA1 gene increased apoptosis, especially in the RGCs carrying c.1198C > G mutation. As a result, mitochondrial dysfunction caused by the c.1198G > C mutation in the OPA1 gene produced a phenotype of visual loss in this Chinese family.
In summary, our findings suggest the pathogenic mechanism leading to an impaired oxidative phosphorylation in lymphoblastoid cell lines cell lines carrying the c.1198C > G mutation in the OPA1 gene. The c.1198C > G mutation alters the mitochondrial morphology and mitochondrial genome maintenance. These defects impaired mitochondrial translation and respiration. As a result, this respiratory deficiency reduced mitochondrial ATP production, increased the production of oxidative reactive species, elevated apoptosis of RGCs and subsequently produced a phenotype of visual loss. Thus, our findings may provide new insights into the understanding of pathophysiology of ADOA.
Materials and Methods
Cell cultures and culture conditions
This study was in compliance with the Declaration of Helsinki. Informed consent, blood samples, and clinical evaluations were obtained from all participating family members, under protocols approved by the Ethic Committees of Zhejiang University and the Wenzhou Medical University. Lymphoblastoid cell lines derived from four members of this Chinese ADOA family 3 vision-impaired members (II-9, III-11, IV-3) carrying the OPA1 c.1198C > G mutation, vision normal member (III-12) lacking the c.1198C > G mutation25, and from two genetically unrelated control individuals (WZ11 and WZ12) lacking any OPA1 mutation but belonging to the same mtDNA haplogroup were immortalized by transformation with the Epstein-Barr virus, as described previously48. Cell lines were grown in RPMI1640 medium (Invitrogen), supplemented with 10% fetal bovine serum.
Mitochondrial network analysis
Cells were cultured on collagen-coated cover glass slips (Thermo Fisher) for 24 hours in the presence of serum. To visualize the mitochondrial network, MitoTracker RedTM (Invitrogen) and 4′, 6-diamidino-2-phenylindole (DAPI; Invitrogen) were employed. The cells grown on cover slips were incubated in growth medium supplemented with 80 nM MitoTracker RedTM for 30 min, stained with DAPI for 15 minutes, and then washed in warm fresh medium, mounted. Cells were examined using a confocal fluorescence microscope (Olympus Flu view FV1000, Japan) with two lasers (Ex/Em = 579/599 nm and 358/461 nm). Mitochondrial morphology was determined in 100 individual cells.
Triple fluorescent staining was performed to detect translocase of outer mitochondrial membrane 20 (TOMM20; Proteintech Group, USA), cytochrome C (Abcam) and nuclei, using 4′, 6-diamidino-2-phenylindole (DAPI; Invitrogen, USA). Cells were cultured on collagen-coated cover glass slips (Thermo Fisher), fixed in 4% formaldehyde for 15 minutes, permeabilized with 0.2% Triton X-100, blocked with 5% Fetal Bovine Serum (FBS) for 1 hour, and immunostained with an anti-TOMM20 antibody and anti-cytochrome C overnight at 4 °C. The cells were then incubated with Alex Fluor 594 goat anti-rabbit IgG (H + L) and Alex Fluor 488 goat anti-mouse IgG (H + L) (Thermo Fisher), stained with DAPI for 15 minutes, and mounted with Fluoromount (Sigma-Aldrich). Cells were examined using a confocal fluorescence microscope (Olympus Fluoview FV1000, Japan) with three lasers (Ex/Em = 550/570 nm, 492/520 nm and 358/461 nm).
Transmission electron microscopy
Specimens were fixed with 2.5% glutaraldehyde in phosphate buffer (0.1 M, pH: 7.0) for more than 4 hours, followed by 1% osmium tetroxide in phosphate buffer (0.1 M, pH: 7.0) for 1–2 hours. Specimens were then dehydrated by a graded series of ethanol, infiltration, and embedded in epoxy resin. Ultrathin sections were stained with uranyl acetate and alkaline lead citrate for 5–10 min respectively and viewed with Hitachi Model H-7650 TEM.
Quantification of mtDNA copy number
Total genomic DNAs were extracted with the MiniBEST Universal Genomic DNA Extraction Kit (TaKaRa) from mutant and control cell lines. 50 ng of DNA was used in each QPCR reaction using Universal SYBR Green Master (Roche Applied Science, Mannheim, Germany) with two pairs of primers for mtDNA (300 nM each) in a 7900 HT Fast Real-time PCR System (Applied Biosystems) with one pair of primers for β-Actin for normalization. The following primers were used: MT-D-loop region: 5′-TCACCCTATTAACCACTCA-3′ (sense) and 5′-AGACAGATACTGCGACATA-3′ (anti-sense); MT-ND1: 5′-CACCCAAGAACAGGGTTTGT-3′ (sense) and 5′-TGGCCATGGGTATGTTGTTAA-3′ (anti-sense); β-Actin: 5′-TCACCCACACTGTGCCCATCTACGA-3′ (sense) and 5′-CAGCGGAACCGCTCATTGCCAATGG-3′ (antisense). mtDNA contents were calculated using the ΔΔCt method whereby all MT-D-loop and MT-ND1 (mtDNA target) Ct values were first normalized to β-Actin. Data from multiple experiments were analyzed using the procedure as described elsewhere49.
Western blotting analysis
Western blotting analysis was performed as detailed previously27, 28. Twenty micrograms of cellular proteins obtained from lysed cells were denatured and loaded on sodium dodecyl sulfate (SDS) polyacrylamide gels. Afterward, the gels were electroblotted onto a polyvinylidene difluoride (PVDF) membrane for hybridization. The antibodies used for this investigation were from Abcam [Anti-ND5, Anti-CO2, Anti-ATP6, VDAC, TOM20, Anti-Cytochrome c], Santa Cruz [Anti-Cytb]; CST [Cleaved PARP, Cleaved Caspase-3, Cleaved Caspase-7, Cleaved Caspase-9]. Peroxidase Affini Pure goat anti-mouse IgG and goat anti-rabbit IgG (Jackson) were used as a secondary antibody and protein signals were detected using the ECL system (CWBIO). Quantification of density in each band was performed as detailed previously27, 28.
Mitochondrial respiration extracellular flux analysis
The rates of oxygen consumption in lymphoblastoid cell lines were measured with a Seahorse Bioscience XF-96 Extracellular Flux Analyzer (Seahorse Bioscience), as detailed previously26, 27. XF96 creates a transient, 7 μl-chamber in specialized microplates that allows for the determination of oxygen and proton concentrations in real time. To allow comparison between different experiments, data are expressed as the rate of oxygen consumption in pmol/min or the rate of extracellular acidification in mpH/min, normalized to cell protein in individual wells determined by the Bradford protein assay (Bio-Rad). A density of 1 × 105 cells per well in 96-well plate was coated with Cell-TakTM adhesive. The rates of O2 were determined under basal condition and the addition of oligomycin (1 μM), carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) (0.5 μM), rotenone (1 μM) and antimycin A (1 μM), as detailed elsewhere26, 27.
Measurement of intracellular ATP levels
The levels of cellular and mitochondrial ATP levels were measured using the ATP Bioluminescence Assay Kit HS II (Roche Applied Science, Mannheim, Germany) according to the manufacturer’s instruction27, 28. In brief, samples of 2 × 106 cells were incubated for 2 hours in the record solution (156 mM NaCl, 3 mM KCl, 2 mM MgSO4, 1.25 mM KH2PO4, 2 mM CaCl2, 20 mM HEPES, pH 7.35) with 10 mM glucose, 10 mM glucose plus 2.5 μg/mL oligomycin (glycolytic ATP generation), or 5 mM 2-deoxy-D-glucose plus 5 mM pyruvate (oxidative ATP production). Cells were lysed and then incubated with the luciferin/luciferase reagents. After 10 min incubation in room temperature, the luminescences were read on a microplate reader (Syneregy H1, Bio-Tek).
Assessment of mitochondrial membrane potential
Mitochondrial membrane potential was assessed with JC-10 Assay Kit Flow Cytometry (Abcam) following general manufacturer’s recommendations with some modifications27. In brief, cells were plated onto 96-well cell culture plate overnight in growth medium. JC-10 dyeloading solution was added for 30 min at 37 °C, 5% CO2. Alternatively, plated cells were preincubated with 10 μM of the protonophore uncoupler carbonyl cyanide 3-chlorophenylhydrazone (CCCP) for 30 min at 37 °C, 5% CO2 prior to staining with JC-10 dye. The fluorescent intensities for both J-aggregates and monomeric forms of JC-10 were analyzed by BD-LSR II flow cytometer system (Beckton Dickson, Inc.) at Ex/Em = 490/525 and 490/590 nm. Ten thousand events were analyzed in each sample.
ROS measurements were performed following the procedures detailed previously30, 50. Briefly, approximate 2 × 106 cells of each cell line were harvested, resuspended in PBS supplemented with 100 μM of 2′,7′- dichlorodihydrofluorescein diacetate (DCFH-DA) and then incubated at 37 °C for 20 min. After washing with PBS twice, cells were resuspended in PBS in the presence of 2 mM freshly prepared H2O2 and 2% FBS and then incubated at room temperature for another 45 min. Cells were further washed with PBS and resuspended with 1 ml of PBS with 0.5% paraformaldehyde. Samples with or without H2O2 stimulation were analyzed by BD-LSR II flow cytometer system (Beckton Dickson, Inc.), with an excitation at 488 nm and emission at 529 nm. Ten thousand events were analyzed in each sample. The levels of ROS generation by mitochondria in living cells were analyzed using the mitochondrial superoxide indictor MitoSOX-Red (Invitrogen), as detailed elsewhere31.
All statistical analyses were performed using Prism software (GraphPad Prism). Significance between two sets of experiments was determined using a Student’s t-test whereas group sets were analyzed using ANOVA. Differences were considered statistically significant when P value < 0.05.
Yu-Wai-Man, P. et al. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Ophthalmology 117, 1538–1546, 1546 e1531 (2010).
Toomes, C. et al. Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy. Hum Mol Genet 10, 1369–1378 (2001).
Yu-Wai-Man, P., Griffiths, P. G. & Chinnery, P. F. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog Retin Eye Res 30, 81–114 (2011).
Lenaers, G. et al. Dominant optic atrophy. Orphanet J Rare Dis 7, 46 (2012).
Yu-Wai-Man, P., Griffiths, P. G., Hudson, G. & Chinnery, P. F. Inherited mitochondrial optic neuropathies. J Med Genet 46, 145–158 (2009).
Ji, Y. et al. Mitochondrial ND1 variants in 1281 Chinese subjects with Leber’s Hereditary Optic Neuropathy. Invest Ophthalmol Vis Sci 57, 2377–2389 (2016).
Jiang, P. et al. Prevalence of mitochondrial ND4 mutations in 1281 Han Chinese subjects with Leber’s Hereditary Optic Neuropathy. Invest Ophthalmol Vis Sci 56, 4778–4788 (2015).
Liang, M. et al. Frequency and spectrum of mitochondrial ND6 mutations in 1218 Han Chinese subjects with Leber’s hereditary optic neuropathy. Invest Ophthalmol Vis Sci 55, 1321–1331 (2014).
Delettre, C. et al. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26, 207–210 (2000).
Reynier, P. et al. OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract. J Med Genet 41, e110 (2004).
Kerrison, J. B. et al. Genetic heterogeneity of dominant optic atrophy, Kjer type: Identification of a second locus on chromosome 18q12.2-12.3. Arch Ophthalmol 117, 805–810 (1999).
Barbet, F. et al. A third locus for dominant optic atrophy on chromosome 22q. J Med Genet 42, 1 (2005).
Carelli, V. et al. Dominant optic atrophy (DOA) and sensorineural hearing loss: clinical, biochemical, spectroscopic and molecular genetic study of a large Italian pedigree linked to a new locus an chromosome 16. Neurology 68, A42 (2007).
Ferre, M. et al. Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data. Hum Mutat 36, 20–25 (2015).
Praefcke, G. J. & McMahon, H. T. The dynamin superfamily: universal membrane tubulation and fission molecules? Nat Rev Mol Cell Biol 5, 133–147 (2004).
Pellegrini, L. & Scorrano, L. A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis. Cell Death Differ 14, 1275–1284 (2007).
Kao, S. H., Yen, M. Y., Wang, A. G., Yeh, Y. L. & Lin, A. L. Changes in mitochondrial morphology and bioenergetics in human lymphoblastoid cells with four novel OPA1 mutations. Invest Ophthalmol Vis Sci 56, 2269–2278 (2015).
Elachouri, G. et al. OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res 21, 12–20 (2011).
Guan, M. X. Cytoplasmic tyrosyl-tRNA synthetase rescues the defect in mitochondrial genome maintenance caused by the nuclear mutation mgm104-1 in the yeast Saccharomyces cerevisiae. Mol Gen Genet. 255, 525–532 (1997).
Landes, T. et al. OPA1 (dys)functions. Semin Cell Dev Biol 21, 593–598 (2010).
Lenaers, G. et al. OPA1 functions in mitochondria and dysfunctions in optic nerve. Int J Biochem Cell Biol 41, 1866–1874 (2009).
Arnoult, D., Grodet, A., Lee, Y. J., Estaquier, J. & Blackstone, C. Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. J Biol Chem 280, 35742–35750 (2005).
Olichon, A. et al. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 278, 7743–7746 (2003).
Gottlieb, E. OPA1 and PARL keep a lid on apoptosis. Cell 126, 27–29 (2006).
Zhang, J. et al. A novel OPA1 mutation in a Chinese family with autosomal dominant optic atrophy. Biochem Biophys Res Commun 419, 670–675 (2012).
Dranka, B. P. et al. Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radic Biol Med 51, 1621–1635 (2011).
Gong, S. et al. A deafness-associated tRNAHis mutation alters the mitochondrial function, ROS production and membrane potential. Nucleic Acids Res 42, 8039–8048 (2014).
Jiang, P. et al. The exome sequencing identified the mutation in YARS2 encoding the mitochondrial tyrosyl-tRNA synthetase as a nuclear modifier for the phenotypic manifestation of Leber’s hereditary optic neuropathy-associated mitochondrial DNA mutation. Hum Mol Genet 25, 584–596 (2016).
Zhou, X. et al. Leber’s Hereditary Optic Neuropathy is associated with the T3866C mutation in mitochondrial ND1 gene in three Han Chinese families. Invest Ophthalmol Vis Sci 53, 4586–4594 (2012).
Mahfouz, R., Sharma, R., Lackner, J., Aziz, N. & Agarwal, A. Evaluation of chemiluminescence and flow cytometry as tools in assessing production of hydrogen peroxide and superoxide anion in human spermatozoa. Fertil. Steril. 92, 819–827 (2009).
Jiang, P. et al. A hypertension-associated tRNAAla mutation alters tRNA metabolism and mitochondrial function. Mol Cell Biol. 36, 1920–1930 (2016).
Winyard, P. G. et al. Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease. Biochem Soc Trans 39, 1226–1232 (2011).
Galloway, C. A., Lee, H. & Yoon, Y. Mitochondrial morphology-emerging role in bioenergetics. Free Radic Biol Med 53, 2218–2228 (2012).
Palmer, C. S., Osellame, L. D., Stojanovski, D. & Ryan, M. T. The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Cell Signal 23, 1534–1545 (2011).
Zorzano, A., Liesa, M., Sebastian, D., Segales, J. & Palacin, M. Mitochondrial fusion proteins: Dual regulators of morphology and metabolism. Semin Cell Dev Biol 21, 566–574 (2010).
Olichon, A. et al. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis. J Cell Physiol 211, 423–430 (2007).
Liao, C. et al. Dysregulated mitophagy and mitochondrial organization in optic atrophy due to OPA1 mutations. Neurology. 88, 131–142 (2017).
Schaaf, C. P. et al. Early-onset severe neuromuscular phenotype associated with compound heterozygosity for OPA1mutations. Mol. Genet. Metab. 103, 383–387 (2011).
James, A. M., Sheard, P. W., Wei, Y. H. & Murphy, M. P. Decreased ATP synthesis is phenotypically expressed during increased energy demand in fibroblasts containing mitochondrial tRNA mutations. Eur J Biochem 259, 462–469 (1999).
Szczepanowska, J., Malinska, D., Wieckowski, M. R. & Duszynski, J. Effect of mtDNA point mutations on cellular bioenergetics. Biochimica et biophysica acta 1817, 1740–1746 (2012).
Lenaz, G. et al. Bioenergetics of mitochondrial diseases associated with mtDNA mutations. Biochim Biophys Acta 1658, 89–94 (2004).
Hayashi, G. & Cortopassi, G. Oxidative stress in inherited mitochondrial diseases. Free Radic Biol Med 88, 10–17 (2015).
Ugarte-Uribe, B. & Garcia-Saez, A. J. Membranes in motion: mitochondrial dynamics and their role in apoptosis. Biol Chem 395, 297–311 (2014).
Sheridan, C. & Martin, S. J. Mitochondrial fission/fusion dynamics and apoptosis. Mitochondrion 10, 640–648 (2010).
Adams, J. M. & Cory, S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr Opin Immunol 19, 488–496 (2007).
Taylor, R. C., Cullen, S. P. & Martin, S. J. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9, 231–241 (2008).
Ju, W. K. et al. Elevated hydrostatic pressure triggers release of OPA1 and cytochrome C, and induces apoptotic cell death in differentiated RGC-5 cells. Mol Vis 15, 120–134 (2009).
Neitzel, H. A routine method for the establishment of permanent growing lymphoblastoid cell. Hum Genet 73, 320–326 (1986).
De Neve, J., Meys, J., Ottoy, J. P., Clement, L. & Thas, O. unifiedWMWqPCR: the unified Wilcoxon-Mann-Whitney test for analyzing RT-qPCR data in R. Bioinformatics 30, 2494–2495 (2014).
Qian, Y., Zhou, X., Liang, M., Qu, J. & Guan, M. X. The altered activity of complex III may contribute to the high penetrance of Leber’s optic neuropathy in a Chinese family carrying the ND4 G11778A mutation. Mitochondrion 11, 871–877 (2011).
This work was supported by grants 31471191, 81200724 and 81400434 from the National Natural Science Foundation of China to M.X.G., J.Z. and Y.J., respectively, and a Project Grant from Wenzhou Science and Technology Bureau (Y20160006) to J.Z.
The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Zhang, J., Liu, X., Liang, X. et al. A novel ADOA-associated OPA1 mutation alters the mitochondrial function, membrane potential, ROS production and apoptosis. Sci Rep 7, 5704 (2017). https://doi.org/10.1038/s41598-017-05571-y
RIPC provides neuroprotection against ischemic stroke by suppressing apoptosis via the mitochondrial pathway
Scientific Reports (2020)
Restoration of L-OPA1 alleviates acute ischemic stroke injury in rats via inhibiting neuronal apoptosis and preserving mitochondrial function
Redox Biology (2020)
Journal of Clinical Investigation (2020)
Opa1 Deficiency Leads to Diminished Mitochondrial Bioenergetics With Compensatory Increased Mitochondrial Motility
Investigative Opthalmology & Visual Science (2020)
κ-opioid receptor activation promotes mitochondrial fusion and enhances myocardial resistance to ischemia and reperfusion injury via STAT3-OPA1 pathway
European Journal of Pharmacology (2020)